Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/51295
Title: Rationale, Design, and Methodology of the MORCOR-TURK Trial: Predictors of In-hospital MORtality in CORonary Care Patients in Turkey
Authors: Kahraman, Fatih
Ersoy, İbrahim
Yılmaz, Ahmet Seyda
Atıcı, Adem
Tekin, Alpin Mert
Açar, Burak
Kaya, Çağlar
Kara, Faruk
Kurt, Feyza
Avcı Demir, Fulya
Çerik, İdris Buğra
Yılmaz, İshak
Adalı, Mehmet Koray
Yeni, Mehtap
Taşcanov, Mustafa Beğenç
Duz, Ramazan
Gülaştı, Sevil
Ömür, Sefa
Topuz, Şahin
Hidayet, Siho
Kaçmaz, Yücel
Aygül, Nazif
Keywords: clinical trial
epidemiology
hospital discharge
hospital mortality
hospitalization
human
multicenter study
patient
turkey (bird)
Hospital Mortality
Hospitalization
Humans
Patient Discharge
Patients
Turkey
Publisher: NLM (Medline)
Abstract: BACKGROUND: Coronary care units are sophisticated clinics established to reduce deaths due to acute cardiovascular events. Current data on coronary care unit mortality rates and predictors of mortality in Turkey are very limited. The MORtality predictors in CORonary care units in TURKey (MORCOR-TURK) trial was designed to provide information on the mortality rates and predictors in patients followed in coronary care units in Turkey. METHODS: The MORCOR-TURK trial will be a national, observational, multicenter, and noninterventional study conducted in Turkey. The study population will include coronary care unit patients from 50 centers selected from all regions in Turkey. All consecutive patients admitted to coronary care units with cardiovascular diagnoses between 1 and 30 September 2022 will be prospectively enrolled. All data will be collected at one point in time, and the current clinical practice will be evaluated (ClinicalTrials.gov number NCT05296694). In the first step of the study, admission diagnoses, demographic characteristics, basic clinical and laboratory data, and in-hospital management will be assessed. At the end of the first step, the predictors and rates of in-hospital mortality will be documented. The second step will be in cohort design, and discharged patients will be followed up till 1 year. Predictors of short- and long-term mortality will be assessed. Moreover, a new coronary care unit mortality score will be generated with data acquired from this cohort. RESULTS: The short-term outcomes of the study are planned to be shared by early 2023. CONCLUSION: The MORCOR-TURK trial will be the largest and most comprehensive study in Turkey evaluating the rates and predictors of in-hospital mortality of patients admitted to coronary care units.
URI: https://doi.org/10.14744/AnatolJCardiol.2022.2824
https://hdl.handle.net/11499/51295
ISSN: 2149-2271
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
document - 2024-04-03T100504.028.pdf2.36 MBAdobe PDFView/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

3
checked on Oct 13, 2024

WEB OF SCIENCETM
Citations

2
checked on Oct 20, 2024

Page view(s)

64
checked on Aug 24, 2024

Download(s)

6
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.